This review highlights high-throughput technologies’ impact on data analysis in genomics and proteomics, indicating their role in biomedical discovery.
High-throughput (HT) biological technologies have transformed the interrogation of molecular and cellular systems, enabling massively parallel, cost-effective measurement of genomic, transcriptomic, proteomic, metabolomic, imaging, and phenotypic data. Analyzing thousands to millions of biological entities simultaneously, these methods underpin systems biology, biomedical discovery, precision medicine, and biotechnology. This review consolidates HT approaches-from sequencing and proteomics to screening, flow/mass cytometry, and highcontent imaging-describing core principles, instrumentation, measurable outputs, and computational analyses. It details experimental design, quality control, bioinformatics workflows, data management, ethical considerations, limitations, and interdisciplinary skills required. Applications across genomics, immunology, oncology, drug discovery, and systems biology are examined, concluding with emerging advances such as integrated single-cell multiomics, spatial profiling, microfluidic automation, and AI-based analysis (Reuter et al., 2015; Gunawan et al., 2023).
No takes yet. Share an insight, caveat, or question.
Shobith Suresh (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: